You are here

  • Home
  • Archive
  • Volume 77, Issue 4
  • Efficacy and safety of tregalizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase IIb, randomised, placebo-controlled trial

Article metrics

Article menu
Download PDFPDF
Clinical and epidemiological research
Concise report
Efficacy and safety of tregalizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase IIb, randomised, placebo-controlled trial

 

Online download statistics by month:

Online download statistics by month: January 2018 to April 2025

AbstractFullPdf
Jan 20182126190127
Feb 20187378253
Mar 20181243260119
Apr 201868414251
May 20184605026
Jun 20183091913
Jul 2018175158
Aug 20181371513
Sep 20181831933
Oct 201813886
Nov 2018116124
Dec 20181441312
Jan 201991229
Feb 2019153195
Mar 20192321911
Apr 20192122210
May 20199883
Jun 2019154136
Jul 201917198
Aug 201922973
Sep 201918583
Oct 201920083
Nov 201917575
Dec 201918072
Jan 2020137104
Feb 2020113124
Mar 2020118112
Apr 2020811121
May 202010949
Jun 20206362
Jul 2020104137
Aug 2020104915
Sep 202011361
Oct 20203447
Nov 20208886
Dec 20206853
Jan 202111159
Feb 20215951
Mar 20217361
Apr 20217773
May 20215131
Jun 2021333
Jul 2021767
Aug 2021543
Sep 202111103
Oct 202110961
Nov 2021120113
Dec 2021180126
Jan 202214483
Feb 20229680
Mar 2022150169
Apr 202213660
May 202213940
Jun 20229431
Jul 202296154
Aug 2022130102
Sep 202210831
Oct 202213972
Nov 20227881
Dec 20229654
Jan 20235642
Feb 202312232
Mar 202310764
Apr 202310941
May 202311766
Jun 202311322
Jul 20233730
Aug 20234500
Sep 20234221
Oct 202382116
Nov 20238141
Dec 20239190
Jan 20246933
Feb 20248361
Mar 20245294
Apr 20246941
May 20245731
Jun 20247522
Jul 20246821
Aug 20245732
Sep 202413164
Oct 20249662
Nov 2024109105
Dec 202481104
Jan 202513590
Feb 20252732
Mar 2025321
Apr 2025541
Total139951380741